Navigation Links
'Re-plumbing' liver helps beat cancer
Date:9/26/2007

Temporarily diverting blood leaving the liver during chemotherapy could prolong the lives of people with primary or secondary liver tumours. The hour-long procedure allows massive doses of chemotherapy drugs to reach the liver and kill the cancer cells without poisoning the rest of the body.

The regime involves injecting the drug straight into the liver, while using catheters and balloons to divert the blood leaving it. This blood is then filtered to remove most of the drug.

The amount of drug getting to the tumour is hundreds of times more than usual, says Richard Taney, president of Delcath Systems, the New York-based company developing the procedure. Patients are given seven times the normal dose of the chemotherapy drug melphalan, but because the drug is prevented from spreading throughout the body its concentration in the liver is far greater than if it had been injected into the circulation.

This increases the chances that tumours will be killed, even if they are too small to be detected individually.

In an early trial on 13 patients, tumours disappeared or shrank by more than half in 10 of the patients within five weeks of their being given the new treatment. They survived for an average of two years. Normally around 90 per cent of people with inoperable secondary liver tumours die within eight months of being diagnosed.

The results will be presented next month at the BioPartnering Europe symposium in London. Delcath Systems has already begun a larger trial in collaboration with a team led by James Pingpank of the US National Cancer Institute in Bethesda, Maryland.

The procedure uses catheters threaded through blood vessels in the thighs and neck, one of which delivers the drug into the hepatic artery, which supplies the liver. Meanwhile, the inferior vena cava, which normally drains the liver, is blocked by a pair of balloons.

To maintain circulation through the liver, a tube runs through one of these balloons. Blood leaving the liver is forced into this tube and out of the body instead of heading for the heart. Were capturing the effluent, says Taney. This blood is then passed through a filter that removes most of the drug, before being returned to the body through the jugular vein. The drug is infused for about 30 minutes, and blood leaving the liver is filtered for an hour.

Adam Markham, senior medical adviser to Cancer Research UK, says any improvements to treatments for cancer that has spread to the liver are welcome. But he cautions that none of the previous surgical attempts to isolate the liver during chemotherapy by clamping blood vessels have worked as well as was hoped. He also warns that even though there is no open surgery, the Delcath procedure might prove too much for very ill patients, and that there would be a risk that at such high concentrations the drug would damage healthy parts of the liver.


'/>"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-611-1212
New Scientist
Source:Eurekalert

Related medicine news :

1. Blood Cells Capable of Regenerating Liver
2. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
3. Infant receives first bloodless liver transplant
4. Liver donors can thrive after transplant
5. Antibiotic induces liver damage in children with E.COLI infections.
6. The Effects Of Delaying A Delivery Questioned
7. Baby Lennox Gets Liver Transplant
8. Milk Thistle Not An Effective Cure For Liver Disease
9. Metronidazole Increases Risk Of Premature Deliveries.
10. Early delivery can prevent cancer
11. A new treatment for liver cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... In his newly appointed role ... May, Ph.D., recently accepted the distinguished Sun Corridor Export Award for his company’s ... (WNB), and 16 other businesses from Pima, Pinal, and Maricopa counties in Arizona, ...
(Date:6/20/2017)... West Hempstead, NY (PRWEB) , ... June 20, ... ... most experienced in the security systems industry has been selected as the partner ... , Amtrak is a passenger railroad service that provides medium- and long-distance intercity ...
(Date:6/20/2017)... ... 2017 , ... John D'Eri, CEO of Rising Tide Car Wash , ... during the Autism Society of America 's 49th annual conference to be ... Foundation (DJFF) was founded in 2002 as the nation's first autism organization focused ...
(Date:6/20/2017)... ... June 20, 2017 , ... MEDI+SIGN, ... like to officially welcome Anthony Stanowski, DHA, FACHE to the MEDI+SIGN Advisory Board. ... and expertise in healthcare will provide invaluable direction for the company,” says Andrew ...
(Date:6/20/2017)... ... , ... The law firm of Momkus McCluskey Roberts LLC congratulates ... DuPage County Bar Association’s Board of Directors. Cassioppi officially took on the leadership role ... Oak Brook. Momkus McCluskey Roberts LLC attorney Stacey A. McCullough was also installed as ...
Breaking Medicine News(10 mins):
(Date:6/1/2017)... , June 1, 2017 Nutriceutical Holdings (NH), ... Recommended Solutions (VRS), and KD Pharma Group have decided ... Holdings by KD Pharma Group. KD Pharma Group will ... option to acquire the entire company. "We ... They are committed to growing the NH companies by ...
(Date:5/26/2017)... -- Endo International plc (NASDAQ: ENDP ) announced today ... the Company in a fireside chat at Goldman Sachs, 38 ... 2017 at 10:40 a.m. PT / 1:40 p.m. ET. The ... Rancho Palos Verdes, CA. A live ... on the Company,s website at http://www.endo.com/investors/overview . Participants should ...
(Date:5/22/2017)... 22, 2017  As the specialty pharmacy industry ... to make the revolutionary shift from volume-based to ... ensuring positive patient outcomes and shaping the future ... focus away from clinical trials and toward data ... specialty drug therapy utilization in precise patient populations. ...
Breaking Medicine Technology: